Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

HIV-1 InfectionHIV Infections

Interventions

DRUG

maraviroc

150 mg tab by mouth once daily for 96 weeks

DRUG

darunavir

800 mg tab by mouth once daily for 96 weeks

DRUG

ritonavir

100 mg capsule by mouth once daily for 96 weeks

Trial Locations (5)

Northwestern University, Chicago

CORECenter, Chicago

Quest Clinical Research, San Francisco

University of Miami, Miami

University of Nebraska, Omaha